BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24699873)

  • 1. Screening for decreased glomerular filtration rate and associated risk factors in a cohort of HIV-infected patients in a middle-income country.
    Santiago P; Grinsztejn B; Friedman RK; Cunha CB; Coelho LE; Luz PM; de Oliveira AV; Moreira RI; Cardoso SW; Veloso VG; Suassuna JH
    PLoS One; 2014; 9(4):e93748. PubMed ID: 24699873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study.
    De Waal R; Cohen K; Fox MP; Stinson K; Maartens G; Boulle A; Igumbor EU; Davies MA
    J Int AIDS Soc; 2017 Apr; 20(1):21317. PubMed ID: 28406595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.
    Kamkuemah M; Kaplan R; Bekker LG; Little F; Myer L
    Trop Med Int Health; 2015 Apr; 20(4):518-26. PubMed ID: 25442109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma cystatin C as a marker for estimated glomerular filtration rate assessment in HIV-1-infected patients treated with dolutegravir-based ART.
    Palich R; Tubiana R; Abdi B; Mestari F; Guiguet M; Imbert-Bismut F; Katlama C; Bonnefont-Rousselot D; Isnard-Bagnis C
    J Antimicrob Chemother; 2018 Jul; 73(7):1935-1939. PubMed ID: 29688533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and factors associated with renal dysfunction among HIV-infected patients.
    Crum-Cianflone N; Ganesan A; Teneza-Mora N; Riddle M; Medina S; Barahona I; Brodine S
    AIDS Patient Care STDS; 2010 Jun; 24(6):353-60. PubMed ID: 20515419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.
    Rasch MG; Engsig FN; Feldt-Rasmussen B; Kirk O; Kronborg G; Pedersen C; Gerstoft J; Obel N
    Scand J Infect Dis; 2012 Sep; 44(9):689-96. PubMed ID: 22680981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors of mild chronic renal failure in HIV-infected patients: influence of female gender and antiretroviral therapy.
    Cristelli MP; Trullàs JC; Cofán F; Rico N; Manzardo C; Ambrosioni J; Bedini JL; Moreno A; Diekmann F; Miro JM;
    Braz J Infect Dis; 2018; 22(3):193-201. PubMed ID: 29782827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of low estimated glomerular filtration rate, proteinuria, and associated risk factors among HIV-infected black patients using Cockroft-Gault and modification of diet in renal disease study equations.
    Longo AL; Lepira FB; Sumaili EK; Makulo JR; Mukumbi H; Bukabau JB; Mokoli VM; Kayembe PK; Nseka NM
    J Acquir Immune Defic Syndr; 2012 Jan; 59(1):59-64. PubMed ID: 21926635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments.
    Achhra AC; Nugent M; Mocroft A; Ryom L; Wyatt CM
    Curr HIV/AIDS Rep; 2016 Jun; 13(3):149-57. PubMed ID: 27130284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy.
    Calza L; Sachs M; Colangeli V; Borderi M; Granozzi B; Malosso P; Comai G; Corradetti V; La Manna G; Viale P
    Clin Exp Nephrol; 2019 Nov; 23(11):1272-1279. PubMed ID: 31327092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CKD-EPI equation: A suitable Glomerular Filtration Rate estimate for drug dosing in HIV-infected patients.
    Gagneux-Brunon A; Botelho-Nevers E; Delanaye P; Lucht F; Frésard A; Cazorla C; Guglielminotti C; Fafin C; Mariat C; Moranne O
    Med Mal Infect; 2017 Jun; 47(4):266-270. PubMed ID: 28499765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz.
    Albini L; Cesana BM; Motta D; Focà E; Gotti D; Calabresi A; Izzo I; Bellagamba R; Fezza R; Narciso P; Sighinolfi L; Maggi P; Quiros-Roldan E; Manili L; Guaraldi G; Lapadula G; Torti C
    J Acquir Immune Defic Syndr; 2012 Jan; 59(1):18-30. PubMed ID: 21992924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic renal failure among HIV-1-infected patients.
    Mocroft A; Kirk O; Gatell J; Reiss P; Gargalianos P; Zilmer K; Beniowski M; Viard JP; Staszewski S; Lundgren JD
    AIDS; 2007 May; 21(9):1119-27. PubMed ID: 17502722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protective role of antiretroviral treatment in the impairment of renal function in a cohort of human immunodeficiency virus patients].
    Mérida L; de la Torre J; Olalla J; Noureddine M; del Arco A; Prada JL; Aguilar A; García-Alegría J
    Med Clin (Barc); 2011 Jun; 137(3):104-7. PubMed ID: 21397277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir.
    Crane HM; Kestenbaum B; Harrington RD; Kitahata MM
    AIDS; 2007 Jul; 21(11):1431-9. PubMed ID: 17589189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients.
    Horberg M; Tang B; Towner W; Silverberg M; Bersoff-Matcha S; Hurley L; Chang J; Blank J; Quesenberry C; Klein D
    J Acquir Immune Defic Syndr; 2010 Jan; 53(1):62-9. PubMed ID: 19838127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors for tenofovir-associated renal function decline among Thai HIV-infected patients with low-body weight.
    Chaisiri K; Bowonwatanuwong C; Kasettratat N; Kiertiburanakul S
    Curr HIV Res; 2010 Oct; 8(7):504-9. PubMed ID: 21073439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of chronic kidney disease in HIV-infected patients.
    Flandre P; Pugliese P; Cuzin L; Bagnis CI; Tack I; Cabié A; Poizot-Martin I; Katlama C; Brunet-François C; Yazdanpanah Y; Dellamonica P;
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1700-7. PubMed ID: 21566114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of liver and renal functions in human immunodeficiency virus-infected persons on highly active antiretroviral therapy: A mixed cohort study.
    Mahajan VK; Wadhwa D; Sharma A; Chauhan S; Vashist S; Kumar P; Chowdhry B
    Indian J Dermatol Venereol Leprol; 2020; 86(5):499-507. PubMed ID: 31975695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal insufficiency in Ghanaian HIV infected patients: need for dose adjustment.
    Owiredu WK; Quaye L; Amidu N; Addai-Mensah O
    Afr Health Sci; 2013 Mar; 13(1):101-11. PubMed ID: 23658575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.